Free Delivery Over $100
|
|
|||
|
||||
OverviewInsulin: Deficiency, Excess and Resistance in Human Disease provides an overview of the role of insulin in the pathogenesis of prevalent non-communicable diseases such as obesity, type 2 diabetes, cardiovascular disease, and cancer, along with a comprehensive review of insulin replacement therapies and novel cardioprotective and insulin-sensitizing drugs. Notable advances in precision diagnosis and therapy for single gene subtypes of diabetes in recent years are also discussed. The discovery of insulin and its lifesaving introduction into clinical practice is one of the most celebrated accomplishments of medical science. However, despite decades of progress and major technical advances, the goal of providing insulin replacement therapy that truly mimics normal physiology remains elusive. Full Product DetailsAuthor: Andrew J. Krentz (Visiting Professor, Institute of Cardiovascular and Metabolic Research, University of Reading, UK)Publisher: Elsevier Science & Technology Imprint: Academic Press Inc Weight: 0.450kg ISBN: 9780323917070ISBN 10: 0323917070 Pages: 444 Publication Date: 22 January 2024 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Unknown Availability: Temporarily unavailable  Table of ContentsReviewsAuthor InformationAndrew Krentz has four decades of clinical and translational research experience in metabolic, endocrine and related cardiovascular disorders. His expertise in the life sciences includes preclinical and early-phase clinical drug development; he has personally contributed translational medical innovations to endocrinology clinical practice. He is actively involved in projects focused on precision diagnostics and therapeutics, digital healthcare, and healthy longevity that bridge the academic-industry spaces. Beyond his expertise in diabetes and endocrinology, he is accredited as a clinical specialist by the European Society for Hypertension and is a member of the Medical, Scientific & Research Committee of Heart UK. He is President-Elect of the Vascular, Lipid & Metabolism section of the Royal Society of Medicine as well as being a member of the European Group for the Study of Insulin Resistance (EGIR) and the Diabetes & Cardiovascular Study Group of the European Association for the Study of Diabetes (EASD). He has authored more than 200 scientific publications and founded the journal Cardiovascular Endocrinology & Metabolism and serves as Editor-in-Chief. Tab Content 6Author Website:Countries AvailableAll regions |
||||
